By Matt Grossman

 

TransMedics Group Inc. shares have had trading halted on the Nasdaq ahead of a regulatory meeting that will review one of the company's products.

The Food and Drug Administration's panel for gastroenterology and urology devices will meet at 9 a.m. ET to discuss TransMedic's liver system, a portable device designed to preserve a donated liver prior to transplant.

Shares of Andover, Mass.-based TransMedics fell by 5.3% on Tuesday, to close at $31.69.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

July 14, 2021 07:34 ET (11:34 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
TransMedics (NASDAQ:TMDX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more TransMedics Charts.
TransMedics (NASDAQ:TMDX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more TransMedics Charts.